Serina Therapeutics, Inc.
SER
$5.65
$0.152.73%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 130.00K | 51.00K | 56.00K | 3.16M | 3.17M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 130.00K | 51.00K | 56.00K | 3.16M | 3.17M |
| Cost of Revenue | 10.88M | 9.33M | 7.48M | 6.02M | 4.21M |
| Gross Profit | -10.75M | -9.27M | -7.42M | -2.87M | -1.04M |
| SG&A Expenses | 10.06M | 9.84M | 8.15M | 6.79M | 4.77M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 20.94M | 19.16M | 15.63M | 12.82M | 8.98M |
| Operating Income | -20.81M | -19.11M | -15.57M | -9.66M | -5.81M |
| Income Before Tax | -12.65M | -1.01M | -11.21M | -7.40M | -7.04M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -12.65 | -1.01 | -11.21 | -7.40 | -7.04 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 62.00K | 75.00K | 66.00K | 54.00K | 27.00K |
| Net Income | -12.59M | -939.00K | -11.14M | -7.35M | -7.01M |
| EBIT | -20.81M | -19.11M | -15.57M | -9.66M | -5.81M |
| EBITDA | -20.66M | -18.92M | -15.38M | -9.52M | -5.67M |
| EPS Basic | -1.58 | -0.31 | -5.20 | -4.18 | -3.53 |
| Normalized Basic EPS | -0.78 | 0.01 | -1.48 | -0.85 | -1.20 |
| EPS Diluted | -1.32 | -0.15 | -5.04 | -4.59 | -4.49 |
| Normalized Diluted EPS | -0.80 | -0.07 | -1.56 | -1.22 | -1.38 |
| Average Basic Shares Outstanding | 47.15M | 45.66M | 38.69M | 22.57M | 15.91M |
| Average Diluted Shares Outstanding | 49.05M | 49.20M | 42.23M | 30.46M | 27.29M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |